Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts.

Kubota, Naoto; Fujiwara, Naoto; Hoshida, Yujin

Kubota, Naoto; Fujiwara, Naoto; Hoshida, Yujin.

Afiliação

Kubota N; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Fujiwara N; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hoshida Y; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address: yujin.hoshida@utsouthwestern.edu.

Adv Cancer Res ; 156: 1-37, 2022.

Article em En | MEDLINE | ID: mdl-35961696

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Hepatopatia Gordurosa não Alcoólica; Biomarcadores; Carcinoma Hepatocelular/diagnóstico; Carcinoma Hepatocelular/epidemiologia; Humanos; Cirrose Hepática/complicações; Cirrose Hepática/diagnóstico; Cirrose Hepática/epidemiologia; Neoplasias Hepáticas/diagnóstico; Neoplasias Hepáticas/epidemiologia; Fatores de Risco

Palavras-chave

Cancer screening; Cirrhosis; Clinical risk score; Hepatocellular carcinoma; Molecular risk score; Precision medicine; Risk prediction

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Adv Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google